Last $63.65 USD
Change Today +4.16 / 6.99%
Volume 2.8M
ISIS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

B. Lynne Parshall Esq., J.D.

Chief Operating Officer, Corporate Secretary, Director and Member of Agenda Committee, Isis Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 47 board members in 3 different organizations across 5 different industries.

See Board Relationships
60$1,751,326
As of Fiscal Year 2013

Background*

Ms. B. Lynne Parshall, Esq., J.D. has been the Chief Operating Officer of Isis Pharmaceuticals, Inc. since December 2007 and serves as its Corporate Secretary. Ms. Parshall served as Secretary at Isis Pharmaceuticals, Inc. since November 1991. Ms. Parshall served as an Executive Vice President since December 1995, Chief Financial Officer from June 1994 to January 2013, Senior Vice President from February 1993 to December 1995 and Vice President from November 1991 to ...

Read Full Background

Corporate Headquarters*

2855 Gazelle Court
Carlsbad, California 92010

United States

Phone: 760-931-9200
Fax: --

Board Members Memberships*

Board Member
Former Director
2000-Present
Chief Operating Officer, Corporate Secretary, Director and Member of Agenda Committee
2005-2009
Director, Chairman of Audit Committee and Member of Nominating & Governance Committee
2005-N/A
Former Director and Chairman of Audit Committee
2009-Present
Director and Member of Audit Committee
2013-Present
Director, Member of Audit Committee and Member of Nominating & Governance Committee

Education*

BA
Harvard University
JD
Stanford University Law school

Other Affiliations*

Annual Compensation*

Salary$641,574
Bonus$526,171
Total Annual Compensation$1,167,745

Stock Options*

Restricted Stock Awards$152,482
All Other Compensation$20,636
Exercised Options405,185
Exercised Options Value$7,641,860
Exercisable Options85,380
Exercisable Options Value$2,610,331
Unexercisable Options115,505
Unexercisable Options Value$3,235,613
Total Value of Options$13,487,804
Total Number of Options606,070

Total Compensation*

Total Annual Cash Compensation$1,188,381
Total Short Term Compensation$1,167,745
Other Long Term Compensation$173,118
Total Calculated Compensation$1,751,326
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISIS:US $63.65 USD +4.16

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Cohen M.D.Founder, Chief Executive Officer, President and Director
Acorda Therapeutics, Inc.
$720.8K
Keith A. Katkin Chief Executive Officer, President, Director, Member of Executive Committee and Member of Pricing Committee
Avanir Pharmaceuticals, Inc.
$611.8K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
--
Uli Hacksell Ph.D.Chief Executive Officer, President and Director
ACADIA Pharmaceuticals Inc.
$935.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ISIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.